Abbott Laboratories (ABT) Net Cash Flow Growth (5y) (2014 - 2026)
Abbott Laboratories (ABT) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.34 Bn | 18.93 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37.07% |
| Mar 31, 2026 | -27.42% |
| Dec 31, 2025 | -15.11% |
| Sep 30, 2025 | 30.44% |
| Jun 30, 2025 | -23.02% |
| Mar 31, 2025 | -21.82% |
| Dec 31, 2024 | 20.56% |
| Sep 30, 2024 | -11.81% |
| Jun 30, 2024 | 44.67% |
| Mar 31, 2024 | 6.96% |
| Dec 31, 2023 | 15.40% |
| Sep 30, 2023 | -17.64% |
| Jun 30, 2023 | -13.62% |
| Mar 31, 2023 | 33.45% |
| Dec 31, 2022 | 16.50% |
| Sep 30, 2022 | -10.52% |
| Jun 30, 2022 | 6.76% |
| Mar 31, 2022 | 26.66% |
| Dec 31, 2021 | -49.94% |
| Sep 30, 2021 | 58.83% |